These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25430867)

  • 21. Deal watch: is deal-making becoming more difficult?
    Borshell N
    Nat Rev Drug Discov; 2011 Jun; 10(6):404. PubMed ID: 21629282
    [No Abstract]   [Full Text] [Related]  

  • 22. Academic virtue in the brave new Britain.
    Lancet; 1990 May; 335(8700):1253. PubMed ID: 1971326
    [No Abstract]   [Full Text] [Related]  

  • 23. Can open-source drug R&D repower pharmaceutical innovation?
    Munos B
    Clin Pharmacol Ther; 2010 May; 87(5):534-6. PubMed ID: 20407458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Grants4Targets - an innovative approach to translate ideas from basic research into novel drugs.
    Lessl M; Schoepe S; Sommer A; Schneider M; Asadullah K
    Drug Discov Today; 2011 Apr; 16(7-8):288-92. PubMed ID: 21129498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitigating risk in academic preclinical drug discovery.
    Dahlin JL; Inglese J; Walters MA
    Nat Rev Drug Discov; 2015 Apr; 14(4):279-94. PubMed ID: 25829283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The future of academic health centers.
    Shine KI
    Physiologist; 1995 Apr; 38(2):51-5. PubMed ID: 7784499
    [No Abstract]   [Full Text] [Related]  

  • 27. The NIH, research institutions and industry: working together on a shared goal.
    Omary MB
    Gastroenterology; 2007 May; 132(5):1647-50. PubMed ID: 17484859
    [No Abstract]   [Full Text] [Related]  

  • 28. The decline and fall of the psychopharmacology empire?
    Norman TR
    Aust N Z J Psychiatry; 2011 Nov; 45(11):1005. PubMed ID: 21985246
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug discovery: new models for industry-academic partnerships.
    Tralau-Stewart CJ; Wyatt CA; Kleyn DE; Ayad A
    Drug Discov Today; 2009 Jan; 14(1-2):95-101. PubMed ID: 18992364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Open innovation: public-private partnerships in pharmaceutical R&D].
    Uchibayashi N
    Nihon Yakurigaku Zasshi; 2013 Jul; 142(1):32-8. PubMed ID: 23842226
    [No Abstract]   [Full Text] [Related]  

  • 31. Open innovation networks between academia and industry: an imperative for breakthrough therapies.
    Melese T; Lin SM; Chang JL; Cohen NH
    Nat Med; 2009 May; 15(5):502-7. PubMed ID: 19424212
    [No Abstract]   [Full Text] [Related]  

  • 32. The significance of health care reform for research, innovations, and academic medicine.
    Pardes H
    Ann N Y Acad Sci; 1994 Nov; 729():132-8; discussion 139-42. PubMed ID: 7998725
    [No Abstract]   [Full Text] [Related]  

  • 33. Trial watch: Opportunities and challenges of the 2016 target landscape.
    Lafferty-Whyte K; Mormeneo D; Del Fresno Marimon M
    Nat Rev Drug Discov; 2017 Jan; 16(1):10-11. PubMed ID: 27980340
    [No Abstract]   [Full Text] [Related]  

  • 34. An audience with... Susan Desmond-Hellmann. Interview by... Asher Mullard.
    Desmond-Hellmann S
    Nat Rev Drug Discov; 2011 Mar; 10(3):170. PubMed ID: 21358729
    [No Abstract]   [Full Text] [Related]  

  • 35. Open access chemical and clinical probes to support drug discovery.
    Edwards AM; Bountra C; Kerr DJ; Willson TM
    Nat Chem Biol; 2009 Jul; 5(7):436-40. PubMed ID: 19536100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The long march of antisense.
    Jones D
    Nat Rev Drug Discov; 2011 Jun; 10(6):401-2. PubMed ID: 21629279
    [No Abstract]   [Full Text] [Related]  

  • 37. Modern phenotypic drug discovery is a viable, neoclassic pharma strategy.
    Lee JA; Uhlik MT; Moxham CM; Tomandl D; Sall DJ
    J Med Chem; 2012 May; 55(10):4527-38. PubMed ID: 22409666
    [No Abstract]   [Full Text] [Related]  

  • 38. Restructurally sound.
    Borrell B
    Nat Med; 2011 May; 17(5):531-3. PubMed ID: 21546961
    [No Abstract]   [Full Text] [Related]  

  • 39. Jay Bradner.
    Nat Rev Drug Discov; 2017 Mar; 16(4):232-233. PubMed ID: 28356589
    [No Abstract]   [Full Text] [Related]  

  • 40. Into the valley of death: research to innovation.
    Hudson J; Khazragui HF
    Drug Discov Today; 2013 Jul; 18(13-14):610-3. PubMed ID: 23402848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.